Please log in to your account or sign up in order to add this asset to your watchlist. View which stocks are hot on social media with MarketBeat's trending stocks report.Identify stocks that meet your criteria using seven unique stock screeners. The biopharmaceutical company reported $0.47 earnings per share for the quarter, beating the Zacks' consensus estimate of ($0.20) by $0.67. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements. On Tuesday, July 28, 2020, the Company, Horizon Therapeutics Public Limited Company, HZNP stock construct a change of 0.65 percent (↑ / Gain) in a total of its share price and having its trading value $59.28, which belongs to Healthcare sector and Drug Manufacturers – General industry. Following the transaction, the director now directly owns 1,755 shares of the company’s stock, valued at […] All rights reserved. Horizon Therapeutics (HZNP) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. We use cookies and browser capability checks to help us deliver our online services, including to learn if you enabled Flash for video or ad blocking. Horizon Therapeutics' stock is owned by a variety of institutional and retail investors. Get short term trading ideas from the MarketBeat Idea Engine. Horizon Therapeutics Public total non-operating income/expense for the twelve months ending March 31, 2020 was $-0.130B, a 5.14% increase year-over-year. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Horizon Therapeutics PLC (NASDAQ:HZNP) Director Michael G. Grey sold 1,755 shares of the stock in a transaction that occurred on Wednesday, July 22nd. In comparing Horizon Therapeutics Public Limited Company (HZNP)’s stock with other industry players reveals that stock’s latest price change of +4.15% and that of +141.74% over the past 12 months is in better position with that of Amgen Inc (AMGN) which saw its stock price fell by -0.53% in the recent trading and went through an increase of 46.63% in past 12-month trading. View our full suite of financial calendars and market data tables, all for free.Receive a free world-class investing education from MarketBeat. View the latest Horizon Therapeutics PLC (HZNP) stock price, news, historical charts, analyst ratings and financial information from WSJ. The biopharmaceutical company earned $30.80 million during the quarter, compared to analyst estimates of $24.60 million. Banque Cantonale Vaudoise lessened its holdings in shares of Horizon Therapeutics PLC (NASDAQ:HZNP) by 28.3% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. There is not enough analysis data for Horizon Therapeutics.Horizon Therapeutics has received Horizon Therapeutics has received Horizon Therapeutics has received 58.45% “outperform” votes from our community.Horizon Therapeutics does not currently pay a dividend.Horizon Therapeutics does not have a long track record of dividend growth.In the past three months, Horizon Therapeutics insiders have not sold or bought any company stock.
© 2020 Market data provided is at least 10-minutes delayed and hosted by The shares were sold at an average price of $60.00, for a total transaction of $105,300.00. © American Consumer News, LLC dba MarketBeat® 2010-2020. Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. "Horizon Therapeutics' mailing address is 2000 Sierra Point Pkwy Ste 400, BRISBANE, CA 94005-1849, United States.